Call for Expression of Interest to attend personalised medicine conference

The Call for Expression of Interest to attend or present at the Conference on Personalised Medicine: Better Healthcare in Cyprus in June 2012 is now open. The deadline is 1 April 2012.

Personalised medicine, enabled by personalised ICT services, and providing genetic and genomic information of every individual, is designed to give each patient an individual therapeutically active drug while minimising the adverse effects. This conference will bring together high-level scientists across scientific domains to support capacity building and increase the impact of personalised medicine research on regulatory bodies, decision makers as well as the private sector.

If you are interested in attending the conference or if you wish to present a small talk or a poster, a Call for Expression of Interest is open until 1 April 2012! A number of conference grants will be available for selected participants, in particular Early Stage Researchers.

Personalised medicine will only be successful when accurate diagnostic tests identify the patients who can benefit from targeted therapies and eventually reach the desired goal of prevention and prediction.

The formidable challenges we are faced with in reaching this goal are numerous. The scope of this conference is to connect high-level scientists across scientific domains, to support capacity building, and increase the impact of personalised medicine research on regulatory bodies, decision makers as well as the private sector.

Sessions will include: - Novelties in ICT for Personalised Medicine - Nanorobots and the Human Body - New Targets and inhibitors based on epigenetic - Natural products as a source for new drugs - Constellation thinking in the diagnosis and therapy -The evolving regulatory system and societal challenges - Empowering the Patient - Roundtables with stakeholders (Patients associations, General Practitioners Associations, Clinician Associations) Confirmed speakers include: Mary Baker - European Brain Council, UK María Berdasco - Bellvitge Biomedical Research Institute (IDIBELL), ES Stephane Berghmans - EMRC, FR Maurizio Botta - University of Siena, IT Jef De Brabander - UT Southwestern Medical Center, US Anne Bruinvels - ELIXIOR, UK Richard Frackowiak - University of Lausanne, CH A. Ganesan - University of East Anglia, UK Ursula Gundert-Remy - Federal Institute for Risk Assessment, DE Manfred Jung - University of Freiburg, DE Jonathan Knowles - EPLS, CH Hans Lehrach - Max Planck Institute for Molecular Genetics, DE Stavros Malas - Minister of Health, CY Emmanuel Mikros - University of Athens, GR Davor Milicic - University of Zagreb, HR Christodoulos Nicolaou - Eli Lilly and Company, US K.C. Nicolaou - The Scripps Research Institute, US David Nutt - Imperial College London, UK Barbara Prainsack - Brunel University London, UK Kamran Sayrafian - NIST, US Dina Simunic - University of Zagreb, HR Albrecht von Müller - Parmenides Foundation, DE A number of conference grants will be available for selected participants, in particular Early Stage Researchers.

http://www.cost.eu/events/pemed